On May 8, 2017, Achillion Pharmaceuticals, Inc. announced that Michael D. Kishbauch, a member of the Board, has resigned from the Audit Committee and the Nominating and Corporate Governance Committee, effective immediately. Mr. Kishbauch will continue to serve on the Board.